Is the Delphi's Oracle Pertinent to Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma? - Reply

J. Annelie Suurmeijer, Marc G. Besselink, Hanneke W. M. van Laarhoven

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Pages (from-to)1851-1852
Number of pages2
JournalJAMA Oncology
Issue number12
Early online date2022
Publication statusPublished - 15 Dec 2022

Cite this